Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...
Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...
Singapore:Â Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic pro...
Singapore:Â The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlot...
Singapore: Carrying a copy of a gene variant called ApoE4 confers a substantially greater risk for Alzheimer's disease o...
Singapore: US Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to Boe...
Singapore: Gilead's drug Sovaldi for hepatitis C virus, GlaxoSmithKline/Theravance's Anoro Ellipta for Chronic Obstructi...
Singapore: Johnson & Johnson has acquired Aragon Pharmaceuticals, a privately-held pharmaceutical discovery and deve...
Singapore: A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-...
Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...
Singapore: Novartis planning to leverage on its R&D pipeline to taste commercial success through 2017. Continuing R&...
Singapore: BRIM Biotechnology has collaborated with Janssen Pharmaceutica to pursue research, development and commercial...
Phylogica, a leading peptide drug discovery company based in Australia, has developed a world-class drug discovery platf...
Singapore: Japanese firm Ono Pharmaceutical and BioFocus, a service division of Galapagos and based in the UK, have sign...
Singapore: Specialty pharmaceutical company Hatchtech successfully completed end-of-phase II (EOP2) consultations with t...
Singapore: Updated results from a phase II study of orteronel, a selective oral 17,20 lyase inhibitor, dosed without pre...
Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...
Singapore:Â GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for...
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the ...
Bangalore: New data from a subgroup analysis of the A1chieve study showed that intensifying treatment with NovoMix 30 (B...
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and pot...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...
Singapore: Gilead Sciences has successfully progressed phase IV Terisa (Type 2 Diabetes Evaluation of Ranolazine in subj...